Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SNPs affecting the clinical outcomes of regularly used immunosuppressants.

Pharmacogenomics - 1 Apr 2018

Meng Huan-Yu, Luo Zhao-Hui, Hu Bo, Jin Wan-Lin, Yan Cheng-Kai, Li Zhi-Bin, Xue Yuan-Yuan, Liu Yu, Luo Yi-En, Xu Li-Qun, Yang Huan

Abstract excerpt

Recent studies have suggested that genomic diversity may play a key role in different clinical outcomes, and the importance of SNPs is becoming increasingly clear. In this article, we summarize the bioactivity of SNPs that may affect the sensitivity to or possibility of drug reactions that occur among the signaling pathways of regularly used immunosuppressants, such as glucocorticoids, azathioprine, tacrolimus,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Computational Biology
Share to Immunosuppressive Agents

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Polymorphism, Single Nucleotide

Share to Precision Medicine

Share to Signal Transduction

Share to Treatment Outcome

Source

Identifiers

PMID: 29517418
DOI: 10.2217/pgs-2017-0182

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SNPs affecting the clinical outcomes of regularly used immunosuppressants.PMID 29517418Read ↗

New challenges and promises in solid organ transplantation pharmacogenetics: the genetic variability of proteins involved in the pharmacodynamics of immunosuppressive drugs.Semantic proximity Read ↗

Pharmacogenomics of adverse drug reactions: practical applications and perspectives.Semantic proximity Read ↗

Pharmacogenetics of immunosuppressants: State of the art and clinical implementation - recommendations from the French National Network of Pharmacogenetics (RNPGx).Semantic proximity Read ↗

Pharmacogenetics of immunosuppressant drugs: A new aspect for individualized therapySemantic proximity Read ↗

Effect of pregnane X receptor polymorphisms on tacrolimus blood concentrations and the resulting adverse reactions in kidney transplantation recipients.Semantic proximity Read ↗

Treatment of Chronic Inflammatory Diseases – The Potential of PharmacogeneticsSemantic proximity Read ↗

Trends in Precision Medicine and Pharmacogenetics as an Adjuvant in Establishing a Correct Immunosuppressive Therapy for Kidney Transplant: An Up-to-Date Historical OverviewSemantic proximity Read ↗

Pharmacogenetics and Predictive Testing of Drug Hypersensitivity ReactionsSemantic proximity Read ↗

Pharmacogenetics: A strategy for personalized medicine for autoimmune diseases.Semantic proximity Read ↗

Update on the Genetic Basis of Drug Hypersensitivity Reactions.Semantic proximity Read ↗

Clinical application of pharmacogenomics: the example of HLA-based drug-induced toxicity.Semantic proximity Read ↗

[Predictive genomic markers for severe adverse drug reactions].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.